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We examined the effect of acute reduction in renal perfusion pressure
on proteinuria and glomerular permselectivity in a model of nephrotoxic
serum nephritis which is characterized by hypertension, heavy protein-
uria and severe structural injury. Sequential dextran sieving studies
were performed after two weeks of nephritis in 10 uninephrectomized
rats at their basal elevated blood pressure levels (154 3 mm Hg) and
at lowered renal perfusion pressure of 105 to 110 mm Hg, achieved by
adjusting a ligature around the aorta above the origin of the renal artery.
Glomerular filtration rate (GFR) decreased from 1.35 0.24 to 0.95
0.19 ml/min (P < 0.002), while urinary protein excretion (factored for
filtration rate) declined from 0.69 0.2 to 0.39 0.1 mg per ml GFR (P
< 0.002) at the lower perfusion pressure. A companion protocol
documented a modest reduction in renal plasma flow (RPF) from 4.96
0.48 to 4.44 0.63 mI/mm (P < 0.05) and a decline in glomerular
transcapillary hydraulic pressure difference (zP) from 43 to 33 mm Hg
(P < 0.001) during the ligature maneuver. In the hypertensive state,
fractional clearances of neutral dextrans (OND) with molecular radii
exceeding 40 A were elevated in nephritic rats as compared to unineph-
rectomized non-nephritic controls. With reduction in renal perfusion
pressure, 0D uniformly declined toward control values and remained
significantly elevated only for molecular radii exceeding 55 A. The
calculated fraction of glomerular filtrate passing through a non-size
discriminatory shunt pathway was 0.93% during the hypertensive
period and was reduced at lower perfusion pressures to 0.52% (to be
compared to 0.19% in controls). These studies demonstrate that gb-
merular size-selective barrier dysfunction in hypertensive nephrotoxic
serum nephritis can be corrected promptly upon reduction in glomeru-
bar hypertension and perfusion.
We have developed a model of nephrotoxic serum nephritis
(NSN) in the uninephrectomized rat which is characterized by
hypertension, heavy proteinuria, and severe structural damage
[1]. Glomerular capillary pressure (PGC) is elevated early,
presumably reflecting impaired autoregulation of gbomerular
perfusion pressure by disease-adapted nephrons in the face of
systemic hypertension [1]. With dextran sieving studies we
have shown that non-size selective shunts develop in the
glomerular basement membrane (GBM), allowing the passage
of large neutral macromolecules into the urine [2]. Long-term
reduction of systemic arterial pressure, PGC and glomerular
plasma flow (QA) with antihypertensive therapy lessened gb-
Received for publication January 27, 1987
and in revised forms July 9, 1987
© 1988 by the International Society of Nephrology
merular structural damage and diminished total protein and
gamma globulin excretion, while achieving normalization of
fractional clearances of large neutral dextrans U, 21.
The studies summarized above do not delineate the precise
mechanism whereby reductions in systemic arterial pressure,
PGC and QA correct the defect in size-selective barrier function
which characterizes this form of NSN. It might be postulated
that elevations of PGC and QA, in aggravating gbomerular
structural damage, lead over time to the development of gb-
merular basement membrane shunts and increased proteinuria,
this sequence being aborted by elimination of intra-organ hy-
pertension. Additionally, or alternatively, defects in permselec-
tivity in this model could be an immediate consequence of
glomerular capillary hypertension. The present study was un-
dertaken to investigate the latter possibility. We have found
that an acute decrease in renal perfusion pressure promptly
reduces proteinuria and the fractional excretion of dextrans
with molecular radii exceeding 40 A in hypertensive NSN.
Thus, our results demonstrate that intra-organ hypertension
directly impairs glomerular permselectivity in hypertensive
NSN.
Methods
NSN was induced in ten uninephrectomized, male Sprague-
Dawley rats as previously described [31. Rats were given
normal saline ad libitum in place of drinking water. Systemic
hypertension develops with this protocol. Two weeks after
induction of nephritis, 24-hour urine specimens were collected
under oil and assayed by colorimetric techniques for total
protein (Bio-Rad Laboratories, Richmond, California, USA)
and for gamma globulin (Sigma Diagnostics, St. Louis, Mis-
souri, USA), and dextran sieving experiments were performed.
Rats anesthetized with intraperitoneal pentobarbital (50 mg/kg)
underwent endotracheal intubation, jugular vein and carotid
artery cannulations, and ureteral or bladder catheterization. A
loose fitting ligature was placed around the abdominal aorta
above the origin of the renal artery. Mean arterial blood
pressure (MAP) was monitored continuously below the abdom-
inal aortic ligature via a femoral artery catheter utilizing a
Statham transducer and a polygraph recorder (Grass Instru-
ments Co., Quincy, Massachusetts, USA). Surgical fluid losses
were replaced with 0.9% saline containing 3H dextran (20 MCi)
and '4C inulin (8 iCi) (New England Nuclear, Boston, Massa-
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chusetts, USA). Neutral dextrans of disperse molecular radii
were prepared as previously described by Chang et al [4]. A
continuous intravenous infusion of 0.9% saline containing 3H
dextran (15 CiIml) and 14C maIm (6 CiIml) was administered
at a rate of 0067 mI/mm. Lissamine green transit time was
determined in each animal to coordinate blood and urine
collections. Blood was withdrawn continuously from the right
carotid artery for 15 minutes at a rate of 0.033 mllmin utilizing
a Harvard pump (Harvard Apparatus, Nitick, Massachusetts,
USA), A 15-minute urine collection was begun after a period of
time had elapsed equal to the transit time. Urine and blood
samples collected during the first experimental period were
utilized in constructing a dextran sieving curve (as will be
described later) at elevated systemic blood pressures averaging
154 mm Hg. Upon conclusion of the initial observations, the
volume of blood removed by the constant withdrawal pump was
replaced with rat plasma. Dextran studies were then repeated
while renal perfusion pressure was reduced and maintained at
105 to 110 mm Hg by tension applied to the aortic ligature.
Urinary protein excretion was determined for each period.
Plasma and urine specimens were assayed for 14C inulin to
determine glomerular filtration rate (GFR) and then fractionated
for 3H dextrans by low-pressure gel filtration techniques using a
gel column calibrated with standard marker proteins (Ultrogel,
AcA 34/AcA 44, LCB Pharmaceuticals). The activity of triti-
ated dextran was determined in each fraction by liquid scintil-
lation counting (Beckman Instruments, Inc., LS7500, Fuller-
ton, California, USA). The void volume of the column was
determined with blue dextran, and the fractional volume avail-
able to the solute (Kay) calculated as: Kay = (VeVo)1Vt'Vo).
V0 is the void volume, e, the elution volume of the solute and
V, the total volume of the column. Stokes-Einstein radii for the
individual dextran fractions were calculated from Kay according
to the method of Granath and Kvist [5]. The sieving coefficient
for dextrans (Cextran/Cinuiin) of a given molecular radius,
0'W' was determined from the ratio: (Urine/Plasma)Dextrafl/
(Urine/Plasma)11. A computer-generated dextran sieving curve
was constructed for each period and displayed graphically.
Seven uninephrectomized normal rats served as controls. In
these animals a single dextran sieving study was performed at
their basal blood pressures.
The effect of the aortic ligature maneuver on renal hemody-
namics was assessed separately in another group of seven rats
studied two weeks after uninephrectomy and induction of NSN.
GFR and RPF were measured by the clearances of inulin and
paraaminohippurate (PAH) at a basal hypertensive arterial
blood-pressure and again at a reduced renal perfusion pressure
achieved by constriction of the aortic ligature. Surgical prepa-
ration was as previously described. Fluid losses were replaced
with 0.9% saline containing 3H nulin (8 MCi) and '4C PAH (6
pCi) (New England Nuclear), A continuous intravenous infu-
sion of saline containing 3H inulin (6 pCi/mI) and '4C PAH (4
pCi/mi) was administered at a rate of 0.067 mI/mm. Clearance
studies were performed after an equilibration period of 60
minutes. Control values for inulin (N = 14) and PAH (N 6)
clearances were obtained under basal conditions in normal rats
two weeks after uninephrectomy.
The effect of acute reduction in perfusion pressure on gb-
merular capillary pressure was measured in four additional rats
two weeks after induction of nephritis. These animals were
prepared for study by micropuncture as previously described
[6]. In their basal hypertensive state (mean arterial blood
pressure 156 2 mm Hg), intratubular pressure (PT) and
stopped-flow intratubular pressure (Ps) were measured in an
early proximal convoluted tubule utilizing a servo-nulling pres-
sure measuring device (Model 900, WP Instruments, New
Haven, Connecticut, USA). As in the dextran studies, renal
perfusion pressure was then reduced to 100 to 110 mm Hg by
application of tension to an abdominal aortic ligature. Stopped-
flow pressure determinations were repeated at the reduced
perfusion pressure. A total of 40 measurements of PSF were
made in these four rats. PGC was then calculated as: PGC PSF
+ ITA, where plasma colloid osmotic pressure (IrA) was deter-
mined from plasma protein concentration by the Landis-Pap-
penheimer equation [11. The glomerular transcapillary hydrau-
lic pressure difference was calculated as: iP = GC — PT.
In order further to characterize glomerular size-selectivity,
we analyzed our data utilizing the heteroporous mathematical
model of the glomerular capillary membrane proposed by Deen
et al [7]. This envisions the glomerular capillary as being
comprised primarily of cylindrical pores of uniform radius
which confer size selectivity, together with a minor population
of large non-size-discriminatory defects that act as transmem-
brane shunts and permit unhindered passage of large neutral
molecules, such as gamma globulin or large molecular weight
dextrans. This model has been shown to best interpret the
dextran sieving data obtained in normal controls and in disease
[71. Utilizing this theoretical model, glomerular capillary wall
function can then be characterized by intrinsic membrane
parameters: Kf, the ultrafiltration coefficient; o, a parameter
which determines the proportion of glomerular filtrate passing
through the shunt pathway; and r0, the radius in angstroms of
the selective pores. For these calculations we utilized values for
glomerular hemodynamics previously determined in our labo-
ratory after two weeks of nephritis for hypertensive nephritic
rats (iW = 43 mm Hg, QA = 160 nblmin, CA = 4.7 mg/dl and
SNFF = 0.35), and two weeks after uninephrectomy in control
rats (P = 36 mm Hg, QA = 196 nl/min, CA 5.7 mg/UI and
SNFF = 0.030). For nephritic rats during the aortic ligature
period, micropuncture studies were performed as part of the
present study (P = 33 mm Hg and CA = 4.7 mgfdl). By
assuming that SNGFR and QA declined in proportion to the fall
in GFR and RPF which we measured, we arrived at most
probable values for SNGFR and QA in nephritic rats after this
maneuver (SNGFR = 44 nI/mm, QA = 143 nl/min and SNFF
0.3 1).
Wilcoxon's rank sum, analysis of variance and paired Stu-
dent's i-test were used for statistical comparisons. Data are
expressed as the mean
Results
After two weeks of NSN, 24-hour urinary protein excretion
was 353 55 mg as compared to 19 4 mg in control rats (P <
0.001). Renal perfusion pressure (MAP as measured in the
femoral artery) was 154 3 mm Hg in nephritics as compared
to 121 3 mm Hg in controls (P <0.001 in Table 1). Glomerular
filtration rate averaged 1.35 0.24 ml/min nephritics, 1.63
0.26 mllmin in controls (NS). Urinary protein excretion was
0.64 0.11 mg/mm in nephritic rats as compared to 0.02
0.002 mg/mm in controls (P < 0.001). Urinary protein excre-
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Control 121 3
NSN-hypertensive 154 3
NSN-aortic ligature 106 1b
- 0.1
C
Q)
U) 0.01
Fig. 1. Sieving coefficients of polydisperse neutral dextrans during
reduction in rena/perfusion pressure in hypertensive nephrotoxic serum
nephritis. For molecular radii exceeding 40 A, fractional clearances in
hypertensive nephritic rats were elevated significantly above control
values (P < 0.05). With reduction in renal perfusion pressure from 154
to 106 mm Hg, fractional clearances of neutral dextrans declined in
nephritic rats to values intermediate between those obtained during the
hypertensive period and those of normal controls. Sieving coefficients
remained abnonnal during decreased pressures only at molecular radii
exceeding 55 A. Symbols are: (A) NSN-hypertensive; (0) NSN-aortic
ligature; (5) control rats.
tion, corrected for GFR, was 0.69 0.19 mg per ml GFR in
nephritic rats as compared to 0.01 0.002 mg/mm per ml (P <
0.001). For molecular radii exceeding 40A, fractional clearances
of neutral dextrans in nephritic rats were elevated significantly
above control values (P < 0.05, Fig. 1).
During the experimental period, renal perfusion pressure was
reduced to 106 1 mm Hg (P < 0.002 compared to 154 3 mm
Hg during the hypertensive period; Table 1). Glomerular filtra-
tion rate fell to 0.95 0.19 mI/mm (P < 0.002). Urinary protein
excretion declined from 0.64 0.11 to 0.34 0.03 mg/mm (P <
0.001). Urinary protein excretion, adjusted for filtration rate,
declined from 0.69 0.19 to 0.39 0.10mg per ml GFR (P <
0.03). During the period of reduced perfusion pressure in
Renal
perfusion
pressure
mm Hg
P"
mm Hg
GFR
mi/mm
RPF
mi/mm
Control 114 2 36 1 1.71 0.21 5.842 0.95
NSN-hypertensive
NSN-aortic ligature
162 l
110 1"
43 2
33 1"
1.35 0.20
1.06 0.2l'
4.96 0.48
4.44 0.63c
a P < 0.001 vs. control, ANOVAb p < 0.001 vs. NSN, paired t-test
P < 0.05 vs. NSN, paired t-test
d Al' as determined during separate micropuncture studies, when
renal perfusion pressures were 156 2 mm Hg and 107 2 mm Hg
before and during aortic ligature.
Control
<w>, %
0.19
Pore radius, A
50.6
NSN-hypertensive 0.93 53.6
NSN-aortic ligature 0.52 51.1
nephritic rats, 9D over the range of molecular radii exceeding
40 A, decreased to values which were intermediate between
those obtained during the hypertensive period and those of
normal controls; in fact, 0ND remained significantly elevated
above control values only for dextrans with molecular radii
exceeding SSA (P < 0.05; Fig. 1).
In a group of nephritic rats who were studied to determine the
effect of the aortic ligature maneuver on renal hemodynamics
(Table 2), MAP was reduced from an initial value of 162 1 mm
Hg to 110 1 mm Hg (P < 0.001). GFR fell from 1.35 0.20
to 1.06 0.21 mllmin (P < 0.001) and RPF declined from 4.96
0.48 to 4.44 0.63 mllmin (P < 0.05). In still another group
studied similarly during micropuncture, PGC averaged 55 I
mm Hg and AP 43 2 mm Hg in hypertensive nephritic rats as
compared to 49 2 mm Hg and 36 2 mm Hg in controls. PGC
declined to 45 1 mm Hg and AP to 33 1 mm Hg after aortic
constriction (P < 0.001).
<w>, the proportion of glomerular filtrate passing through
the shunt pathway, was calculated as 0.93% in nephritics as
compared to 0.19% in controls, while r0 was 53.6 A in nephritics
and 50.6 A in controls (Table 3). <w> declined to 0.52% during
the ligature period; r0 decreased slightly to 51.1 A.
Discussion
Mild nephrotoxic serum nephritis is accompanied by in-
creases in PGC, which occur presumably as an adaptation to a
reduced glomerular capillary ultrafiltration coefficient [1]. It has
been proposed that the elevated PGC occurring in experimental
glomerulonephritis may be maladaptive in accelerating morpho-
logic damage and functional deterioration [8]. Systemic hyper-
tension, by further elevating POC in the nephritic kidney, may
aggravate vascular and glomerular damage [9]. Our model of
nephrotoxic serum nephritis is characterized early by systemic
hypertension, elevated glomerular capillary pressure, severe
proteinuria and the ultimate development of glomerular and
vascular sclerosis [1]. We have shown that normalization of
Table 1. Effect of reduction in renal perfusion pressure on filtration
rate adjusted proteinuria in hypertensive NSN
Renal
perfusion
pressure
mm Hg
Table 2. Effect of reduction in renal perfusion pressure on renal
hemodynamics in hypertensive NSN
GFR
mi/mm
1.63 0.26
1.35 0.24
0.95 019b
Urinary
protein
excretion
mg per ml
GFR
0.01 0.002
0.69 0.l9a
0.39 0.l0
a P < 0.001 vs. control, ANOVA
b P < 0.002 vs. NSN, paired t-test
P < 0.03 vs. NSN, paired t-test
1.0
Table 3. Effect of reduction in renal perfusion pressure on the shunt
pathway and pore radius in hypertensive NSN
0.001
20 40 60
Dextran radius, A
80
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systemic hypertension with long-term antihypertensive therapy
lessens total urinary protein and gamma globulin excretion and
aborts the development of glomerular and vascular structural
damage [1]. Attendant reductions in glomerular capillary pres-
sure and glomerular plasma flow rate support a role for intra-
organ hypertension in the pathogenesis of glomerular damage in
this hypertensive form of NSN.
Based on an analysis of dextran sieving coefficients and on
the model of glomerular permselectivity proposed by Deen and
coworkers [71, we have previously demonstrated a population
of non-selective shunts in the glomerular basement membrane
of hypertensive nephritic rats [21. These basement membrane
defects, nondiscriminatory with respect to size, form a shunt
pathway for the filtration of small as well as large, otherwise
impermeant macromolecules such as gamma globulin. Anti-
hypertensive therapy with hydralazine, reserpine and hydro-
chlorothiazide lessened proteinuria, normalized °ND and de-
creased the proportion of filtrate passing through this shunt
pathway by 10-fold [21. Assessment of glomerular hemodynam-
ics after two weeks of treatment showed a reduction in single
nephron glomerular filtration rate, glomerular capillary pressure
and glomerular plasma flow rate [1]. It might be postulated that
treatment of hypertension, in reducing glomerular pressures
and flows, limits the development of structural damage, thus
preventing the formation of basement membrane defects which
act as transmembrane shunts. Additionally, or alternately, the
possibility must be considered that glomerular capillary hyper-
tension may influence glomerular permselectivity directly.
The present study was undertaken to determine whether the
level of renal perfusion pressure directly influences glomerular
size permselectivity in NSN by affecting the shunt pathway.
The results demonstrate that systemic hypertension does, in
fact, directly impair glomerular size-selective barrier function in
NSN. Decreasing arterial and glomerular capillary pressures
promptly reduced proteinuria (adjusted for filtration rate) and
excessive fractional clearances of dextrans with molecular radii
exceeding 40 A. This occurred in association with nearly a 50%
reduction in the calculated proportion of filtrate passing through
the shunt pathway. Although a contributory role for decreased
glomerular blood flow is possible, these data establish that
correction of intra-organ hypertension has an immediate salu-
tary effect on glomerular size permselectivity in hypertensive
NSN.
Several studies from other laboratories have demonstrated an
effect of acute changes in renal hemodynamics on glomerular
permselectivity. Pressor or subpressor doses of angiotensin II
(All) when infused into normal or proteinuric rats markedly
enhance urinary protein excretion [10—14]. A rise in glomerular
capillary pressure offsets a decline in glomerular plasma flow
rate, maintaining single nephron filtration rate at basal levels
[11]. As shown by Bohrer et al, All-induced proteinuria is
accompanied by elevated fractional clearances of both neutral
and anionic dextrans of molecular radius exceeding 22 A [11].
Yoshioka et al demonstrated a rise in All levels and an increase
in proteinuria with acute partial renal vein constriction [15];
<w> increased as did 0ND for molecular radii exceeding 44 A.
Glomerular capillary pressure rose while QA and single nephron
filtration rate (SNGFR) fell. Infusion of saralasin during renal
vein constriction normalized P6c and SNGFR and increased QA
toward baseline, associated with a partial correction of °NDand
reductions in <w> and proteinuria toward baseline. These data
suggest that an All mediated elevation in GC and increased
utilization of the shunt pathway account for the defect in
glomerular permselectivity observed. In a model of heterolo-
gous immune complex nephritis, heavy proteinuna is associ-
ated with increased PGC and elevated 0ND for molecular radii
exceeding 52 A [16]. Infusion of All further increased protein-
uria and 0ND' associated with an increase in P and a fall in QA,
SNGFR remaining constant. In contrast, acetylcholine infusion
reduced proteinuria and partially corrected basally elevated
9ND associated with a reduction in i.P and an increase in QA,
SNGFR remaining constant. Similarly, the ablation model in
the rat is characterized by elevated glomerular hemodynamics,
proteinuria and increased 0ND for molecular radii exceeding 36
A [17, 18]. Administration of verapamil normalizes PGC and
markedly reduces proteinuria [17].
Shemesh et al have shown that in patients with membranous
nephropathy and heavy proteinuria, 9ND is reduced for dextrans
of molecular radii 28 to 48 A, but elevated for those exceeding
so A [19]. Lowering of arterial pressure, glomerular filtration
rate and renal blood flow with indomethacin decreased frac-
tional excretion of albumin and gamma globulin due to a
reduction in <w>. It was suggested that reductions in PGC and
QA might promote reduced utililzation of the shunt pathway. In
patients with glomerular disease and heavy proteinuria, colloid
volume expansion increases the fractional excretion of neutral
dextrans with molecular radius exceeding 40 A and the frac-
tional clearances of albumin and IgG [201. An increase in <w>
accounts for this enhancement of a pre-existing defect in
glomerular size permselectivity. It was hypothesized that this
alteration in permselectivity resulted from increases in PGC and
QA.
Aortic clamping in nephritic rats would be expected to
stimulate renin release, increase generation of angiotensin II,
and increase prostaglandin synthesis [21]. Increased levels of
All would be expected to aggravate rather than reduce protein-
uria in nephritic animals, (as has been demonstrated in the case
of aminonucleoside-treated rats) by mechanisms discussed ear-
lier [10—14]. A possible role of prostaglandins as influenced by
the generation of All must also be considered [22]. However, a
reduction in proteinuria through vasodilator prostaglandins can
likely be dismissed in view of the improvement in glomerular
permselectivity which is induced by prostaglandin inhibitors in
proteinuric animals and in nephrotic man [19, 23, 24].
We cannot assess the relative importance of reduced P
versus a decline in QA in restoring glomerular barrier function.
Several experimental manipulations which enhance proteinuria
do so while elevating POC and reducing QA, SNGFR remaining
constant. These include partial renal vein constriction and All
infusion in normal rats and in rats with heterologous immune
complex nephritis [11, 15, 16]. In these studies, elevation of PGC
alone increased proteinuria and 0ND for large dextrans, despite
a fall in QA, suggesting an important but not necessarily
exclusive role for intraglomerular pressure in enhanced utililza-
tion of the shunt pathway.
Reprint requests to Dr. David S. Baldwin, Hypertension and Renal
Disease Section, Department of Medicine, New York University School
of Medicine, New York, New York 10016, USA.
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